Skip to main content
Clinical Trials/CTIS2023-510388-37-00
CTIS2023-510388-37-00
Active, not recruiting
Phase 1

The effect of suprainguinal fascia iliaca compartment blockA healthy volunteer trial - SIFICB

Region Midtjylland0 sites20 target enrollmentFebruary 2, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Region Midtjylland
Enrollment
20
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Region Midtjylland

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists physical status classification score (ASA) I\-II, Age \= 18 years, BMI \< 25 kg/m², Able to read and understand Danish as well as read, understand and sign informed written consent, Weight \= 69 kg

Exclusion Criteria

  • Inability to cooperate, Decreased sense of touch on the lower extremities assessed by examination by the investigator before the start of the trial, Known coagulopathy, Infection in the areas of insertion sites for nerve blocks and EMG examination, Allergy to local analgesics used in the study (Ropivacaine), Allergy to contrast agents for MR scanning (Gadoteric acid), Daily medication consumption besides oral contraception, Abuse of alcohol, drugs or medication, Pregnancy, Unable to speak and understand Danish, Fear of needles, Claustrophobia, Metallic implants in the body incl. pacemaker, Known reduced kidney function, Known reduced liver function, Previously operated on in the hip area or groin, Known neuropathy in the lower extremities

Outcomes

Primary Outcomes

Not specified

Similar Trials